Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Your provider determines whether peptide therapy is appropriate based on your health context
The combination with Cagrilintide is not studied in the literature and theoretically: Cagrilintide + Tirzepatide would lead to a three-way appetite suppression (GIP + GLP-1 + amylin), potentially supra-additive, but with the risk of strong nausea and loss of muscle mass Cagrilintide + Retatrutide would be a four-way activation, highly speculative For research it is an alternative, not a combination , choose one strategy
the final vial is independently verified by Janoshik Analytical
Total weight loss at 48-68 weeks on the combination is difficult to predict without clinical trial data, but based on individual compound data (retatrutide at 24-28.7% and the additive benefit seen with CagriSema), a reasonable estimate for the combination is 25-35% total body weight reduction in high responders
The choice between these forms can be important, which is why consulting with a professional is so helpful for creating a plan that aligns with your wellness goals
